The appeal of the LP-IR is its early-warning potential. Standard glucose tests show trouble only after blood sugar starts to ...
For patients who want a closer look at metabolic risk, several specialized tests go beyond standard glucose measurements.
Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer ...
Sugar alternatives are thought to be better for short-term blood sugar management than regular sugar. Sugar alternatives ...
Objectives Despite adherence to guideline-based pharmacotherapy, many people with diabetic kidney disease (DKD) were unable to meet glycaemic and blood pressure targets. The purpose of this paper was ...